Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Protein-Based Liquid Biopsy Panel Assesses Tumor Microenvironment, Shows Prognostic Potential
Premium
A panel of 13 circulating proteins related to the tumor microenvironment may provide prognostic clues to prostate cancer progression.
Guardant Health Begins SHIELD Trial for Lung Cancer Early Detection
The company will enroll 10,000 high-risk patients in the trial and evaluate the ability of its SHIELD blood test to detect lung cancer early.
FDA Clears Kinnate Biopharma's IND for FGFR Inhibitor in Bile Duct, Urothelial Cancers
The firm will begin a trial evaluating KIN-3248 as a treatment for patients with FGFR2/3-altered tumors during the first half of 2022.
Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay
The diagnostics and research services firm will help Mainz recruit research partners for a study assessing new biomarker additions to its CRC early detection test.
During its R&D day, 23andMe outlined the genetics rationale for two cancer drugs it is developing and said it will apply genotyping across trials to identify best responders.